Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | P4HB | P07237 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | MAOB | P27338 | 5/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | FBP1 | P09467 | 1/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | TNKS | O95271 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80207 | 1.00 | NPSR1 (0.64) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| SCHEMBL29426408 | 1.00 | NPSR1 (0.64) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| SCHEMBL15673342 | 1.00 | NPSR1 (0.64) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| Hydrochloric Acid SCHEMBL4095648 | 0.98 | P4HB (0.62) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| Ethane SCHEMBL9580381 | 0.97 | P4HB (0.61) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| Guanidine SCHEMBL8055577 | 0.91 | NPSR1 (0.56) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| SCHEMBL10585234 | 0.89 | P4HB (0.56) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| SCHEMBL6781559 | 0.89 | P4HB (0.56) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| SCHEMBL20546818 | 0.88 | MAOB (0.55) | NPSR1P4HBMEN1LMNAHSP90AA1 | |
| SCHEMBL17061419 | 0.88 | P4HB (0.66) | NPSR1P4HBMEN1LMNAHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119977785-A | Method for simply synthesizing m-trifluoromethyl cinnamic acid | 台州爱申特科技有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119243217-A | For low pressure CO2Electro-reduction catalyst, preparation method and application thereof | 苏州西热节能环保技术有限公司 | 2025-01-03 | — | — | CN | claimed |
| CN-118389026-B | Petroleum conveying pipe and production method thereof | 河北品华管业有限公司 | 2024-09-03 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118389026-A | Petroleum conveying pipe and production method thereof | 河北品华管业有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-113896845-B | Low-sensitivity slow-release polycarboxylic acid slump retaining agent and preparation method thereof | 科之杰新材料集团有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-113980198-B | Sustained-release controllable polycarboxylic acid slump retaining agent and preparation method thereof | 科之杰新材料集团有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-112708054-B | Polycarboxylate superplasticizer for concrete member and preparation method thereof | 科之杰新材料集团河南有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-112708056-B | Viscosity-reducing polycarboxylate superplasticizer for concrete member and preparation method thereof | 科之杰新材料集团河南有限公司 | 2022-10-18 | — | — | CN | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| US-20050256149-A1 | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-11-17 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050161666-A1 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-07-28 | — | — | US | claimed |
| US-6919325-B2 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2005-07-19 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1526584-A2 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | Samsung Electronics Co., Ltd (KR) | 2005-04-27 | — | — | EP | claimed |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-07-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256149-A1 | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts | ADRB3, ADRB1, HSD3B1 | NPSR1 1297/4885P4HB 4196/4885MEN1 3928/4885 |
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | NPSR1 2989/4885P4HB 2317/4885MEN1 685/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | NPSR1 3033/4885P4HB 1168/4885MEN1 1466/4885 |
| US-20030130300-A1 | Respiratory system disorders; synergistic mixtures | ADRB3, ADRB1, CHRM3 | NPSR1 500/4885P4HB 4264/4885MEN1 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.